OEL

University of Austin (UATX), Launches Debate Society, the Austin Union

Retrieved on: 
Monday, March 4, 2024
SXSW, Fellow, OEL, New York Law School, Individual, UATX, Constitutional law, Government, American Civil Liberties Union, Debate, University, Importance, Constitution, Union, Oxford Union, History, Economics, ACLU, Environment, Education, Democracy, Management

AUSTIN, Texas, March 4, 2024 /PRNewswire/ -- Today, the University of Austin (UATX), America's newest university dedicated to the fearless pursuit of truth and fostering an environment of intellectual freedom and pluralism, announced the launch of the Austin Union, a debate society. To honor the commencement, the University is hosting an event on Saturday, March 9th, during SXSW, featuring special guest Robert F. Kennedy, Jr. alongside former ACLU head Nadine Strossen.

Key Points: 
  • The Austin Union Manifesto declares: "No mind can grow without some sort of resistance.
  • Hagye says, "I was inspired by the storied Oxford Union, which I experienced during my studies at Oxford a few years ago.
  • "It's our goal that over time, the Austin Union will -- like Oxford's -- become a fully student-run organization," Hagye added.
  • The Austin Union audience can expect a respectful appreciation of opposing views, with enough disagreement to spur continuing discussion of decisions of great importance to all Americans."

Expanding Capabilities for Clients: Olon to Open New High Potency API Suite in US

Retrieved on: 
Tuesday, January 30, 2024
Growth, GMP, API, OEL, Fine chemical

MILAN, Italy, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Olon Group announces the construction of a cutting-edge High Potency API suite.

Key Points: 
  • MILAN, Italy, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Olon Group announces the construction of a cutting-edge High Potency API suite.
  • A GMP High Potency Active Pharmaceutical Ingredient (HPAPI) suite, currently under construction at the Olon USA site in Concord, Ohio, is the center of excellence for early development of APIs within the Olon Group.
  • “Our High Potency API suite is not just a facility; it's a gateway to new possibilities.
  • The High Potency API suite will provide a secure and self-contained environment for working with these materials, ensuring the safety of our operators and staff as they develop the synthetic process or manufacture your clinical grade materials.

PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site

Retrieved on: 
Wednesday, December 27, 2023
Multimedia, API, Research, Spacecraft, OEL, CMC, Occupational exposure limit, GMP, Peptide, Oligonucleotide, ADC, Fine chemical

NANJING, China, Dec. 26, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has announced opening of a new high potency API (HPAPI) GMP facility (OEB-5 and above) at its Zhejiang manufacturing site.

Key Points: 
  • NANJING, China, Dec. 26, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has announced opening of a new high potency API (HPAPI) GMP facility (OEB-5 and above) at its Zhejiang manufacturing site.
  • The new HPAPI GMP facility enables PharmaBlock to offer process R&D and kilo-scale production of HPAPIs and ADC toxins.
  • In addition to this new GMP HPAPI facility, multiple workshops at PharmaBlock Zhejiang are capable to manufacture OEB-4 compounds.
  • The new HPAPI GMP facility is a crucial addition to support the delivery of ADC projects to global partners.

Press release - Exposure to asbestos: MEPs adopt law to protect workers more robustly

Retrieved on: 
Wednesday, October 4, 2023
Pillar, Adoption, Technology, OEL, Asbestos, Clothing, Member of the European Parliament, Social Affairs Committee (French National Assembly), Véronique, Parliament, Employment, RO, European Pillar of Social Rights, Directive, Risk, Conference on the Future of Europe, European Green Deal, Véronique Trillet-Lenoir, Health, Occupational cancer, Conference, Legislation, Glass fiber, Spinning (textiles), Plaster, EU

Lower level of exposure

Key Points: 
  • Lower level of exposure
    The law aims to reduce exposure to asbestos fibres to the lowest possible level.
  • The new rules also include new requirements to protect workers more robustly.
  • These new rules on asbestos drastically reduce the level of asbestos that workers are exposed to, protecting them from the dangerous carcinogen.
  • It is by far the biggest cause of work-related cancer: 78% of occupational cancers recognised in EU member states are related to asbestos exposure.

OLON Enters in ADC Market

Retrieved on: 
Tuesday, May 30, 2023
GMP, OEL, Senior, QC, Hook effect, API, Fermentation, Research, CDMO, Olon Süme, Anthracycline, Medicine, Quality control, Growth, Spacecraft, Safety, Fine chemical, Vaccine, Rodano, Camptothecin

The ultra-high-containment production line will produce high-potency and toxic products and will therefore reach containment level OEB6 (target OEL 10 ng/m3).

Key Points: 
  • The ultra-high-containment production line will produce high-potency and toxic products and will therefore reach containment level OEB6 (target OEL 10 ng/m3).
  • This complete, closed-loop system will include all steps of the process: synthesis, isolation, drying and analysis: an ultra-high-containment plant.
  • Olon is one of few suppliers in the global API market able to integrate every level of containment from the initial API development to commercial manufacturing and from a few grams to hundreds of kilograms.
  • Olon has a global network of 11 manufacturing sites and 7 R&D centers across the globe.

Highlights - Protection of workers from the risks related to exposure to asbestos at work - Committee on Employment and Social Affairs

Retrieved on: 
Monday, February 13, 2023
European Parliament, European Parliament Committee on Employment and Social Affairs, Commission, Employment, INI, Committee, Ministry of Social Affairs, OEL, Asbestos, Seat of the European Parliament in Strasbourg, Personal protective equipment

Protection of workers from the risks related to exposure to asbestos at work

Key Points: 
  • Protection of workers from the risks related to exposure to asbestos at work
    10-02-2023 - 09:11
    The Committee on Employment and Social Affairs discussed the draft report on the Commission proposal for a Directive on the protection of workers from the risks related to exposure to asbestos at work.
  • The proposal is part of the Asbestos Package presented by the Commission in September 2022, which builds on the European Parliament's legislative INI on protecting workers from asbestos.
  • By lowering the occupational exposure limit (OEL) value by ten times compared to the one currently in place, the revised directive is expected to considerably improve workers' protection, while also providing training and guidance to employers.
  • The committee is looking forward to continuing the work on this key Directive, which will be a step forward towards an asbestos-free Europe and for a people-centred green transition.

VelocityEHS® Named a Leader in latest EHS Software Green Quadrant, Earning High Scores for Ergonomics, Industrial Hygiene, Chemical Management, and Environmental Management

Retrieved on: 
Wednesday, January 4, 2023
Carbon, Hazardous waste, Industry analyst, The Chartered Institute of Ergonomics and Human Factors, OSHA, ESG, Green chemistry, Strategic Approach to International Chemicals Management, Water, Hygiene, Wastewater treatment, ML, Architecture, National Safety Council, Research, B2B, Medco Health Solutions, Acceleration, CVC, Process safety management, Face, Safety, GQ, Software, CIOS, IH, EHS, Software as a service, OEL, Partners Group, Environment, Online shopping, Risk management, EU

The report advises EHS software buyers that VelocityEHS should be shortlisted by “Enterprise and mid-market customers looking for a scalable, innovative, integrated platform.”

Key Points: 
  • The report advises EHS software buyers that VelocityEHS should be shortlisted by “Enterprise and mid-market customers looking for a scalable, innovative, integrated platform.”
    This year’s Green Quadrant (GQ) report marks the fourth consecutive time VelocityEHS has been named a Leader for EHS Software.
  • The new research spotlights VelocityEHS strengths in AI-enabled ergonomics, green chemistry, industrial hygiene, hazardous waste, chemical management and the management of water and wastewater.
  • Verdantix also named VelocityEHS a Leader in its latest Green Quadrants for Carbon Management and Process Safety Management.
  • “VelocityEHS designed its Accelerate platform to be a true cloud-native software as a service (SaaS) solution for fast and simpler deployments for its customers.

WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility

Retrieved on: 
Monday, September 26, 2022
CMC, Tablet, HP, Industry, Patient, CEO, Technology, Contract manufacturing organization, OEL, Drug development, CPT, Wuxi, Multimedia, Contract research organization, View, Fine chemical

SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of its first high potency (HP) oral drug product manufacturing facility at its Wuxi city campus. This new facility marks a milestone for WuXi STA to further extend its drug product capacity and capabilities to meet the growing demand for HP drug candidate development and manufacturing services.

Key Points: 
  • SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of its first high potency (HP) oral drug product manufacturing facility at its Wuxi city campus.
  • With this new facility, WuXi STA is well positioned to provide an integrated R&D and manufacturing network for high potency active pharmaceutical ingredients (HPAPI) and drug product from preclinical to commercial manufacturing.
  • Dr. Minzhang Chen, Co-CEO of WuXi AppTec and CEO of WuXi STA, commented, "We are delighted to announce the opening of our first drug product manufacturing facility for high potency oral products.
  • Last year, WuXi STA established its first Europe-based drug product manufacturing facility in Couvet, Switzerland, which provides tablet & capsule commercial manufacturing and packaging capabilities.

HAS Healthcare Advanced Synthesis (HAS, Formerly Helsinn Advanced Synthesis SA) Has Improved its ECOVADIS Sustainability Rating From Silver to Gold Status in One Year

Retrieved on: 
Wednesday, September 7, 2022
Carbon, CEO, Solution, Active ingredient, Swissmedic, Human rights, Sustainable procurement, Organization, Labour, API, Environment, CDMO, FDA, Gold, HAS, OEL, Anticarcinogen, Industry, Fine chemical, Ethics

BIASCA, Switzerland, Sep. 7, 2022 /PRNewswire-PRWeb/ -- Biasca, Switzerland, September 1st, 2022 – HAS Healthcare Advanced Synthesis SA ("HAS"), a full-service contract development and manufacturing organization (CDMO) delivering high-quality, exclusive, personalized solutions to its healthcare clients, today announces that EcoVadis, the world's largest and most trusted provider of business sustainability ratings, creating a global network of more than 90,000+ rated companies, has awarded HAS a gold rating for 2022. The new gold rating places HAS in the top 6% of all the companies assessed worldwide, and in the top 3% in the category 'Manufacture of basic pharmaceutical products and pharmaceutical preparations' by EcoVadis.

Key Points: 
  • EcoVadis rates companies in the four main topic areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
  • Our gold rating is confirmation that sustainability is fully embedded in our business model.
  • HAS Healthcare Advanced Synthesis is a full-service CDMO committed to providing a reliable, first-class and tailor-made offering.
  • Please visit our new website: https://www.hashealthcare.com
    Sandra Moro, HAS Healthcare Advanced Synthesis, 41 (0) 91 873 94 30, [email protected]

Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site

Retrieved on: 
Tuesday, July 12, 2022
Economy, McNeil Consumer Healthcare, Achievement, Allergan, CAD, Occupational exposure limit, Vaccine, Solution, Piramal, PPS, Filtration, Patient, The Carlyle Group, Spasticity, Policy, OEL, PPL, PCC, Contract, Commerce, Ophthalmology, CDMO, API, Economic development, Growth, Pain management, Partnership, Fine chemical

MUMBAI, India, July 12, 2022 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario.

Key Points: 
  • - New plant includes reactor suites, filtration, and drying capabilities
    MUMBAI, India, July 12, 2022 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario.
  • Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions said, "This new plant is just the latest in a series of expansions and capability upgrades at Aurora, with more to follow.
  • The Honorable Tom Mrakas, Mayor of Aurora, stated, "The opening of this plant is an exciting moment for the town of Aurora.
  • Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle.